Saudi Arabia Autism Spectrum Disorder Treatment Market Size & Outlook

The autism spectrum disorder treatment market in Saudi Arabia is expected to reach a projected revenue of US$ 15.2 million by 2033. A compound annual growth rate of 6.6% is expected of Saudi Arabia autism spectrum disorder treatment market from 2025 to 2033.
Revenue, 2024 (US$M)
$8.5
Forecast, 2033 (US$M)
$15.2
CAGR, 2025 - 2033
6.6%
Report Coverage
Saudi Arabia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia autism spectrum disorder treatment market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Saudi Arabia autism spectrum disorder treatment market highlights

  • The Saudi Arabia autism spectrum disorder treatment market generated a revenue of USD 8.5 million in 2024 and is expected to reach USD 15.2 million by 2033.
  • The Saudi Arabia market is expected to grow at a CAGR of 6.6% from 2025 to 2033.
  • In terms of segment, antipsychotic drugs was the largest revenue generating treatment in 2024.
  • Stimulants is the most lucrative treatment segment registering the fastest growth during the forecast period.


Autism spectrum disorder treatment market data book summary

Market revenue in 2024USD 8.5 million
Market revenue in 2033USD 15.2 million
Growth rate6.6% (CAGR from 2025 to 2033)
Largest segmentAntipsychotic drugs
Fastest growing segmentStimulants
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAntipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications
Key market players worldwideBristol-Myers Squibb Co, Merck & Co Inc, Novartis AG ADR, Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Otsuka Pharmaceutical, Roche Holding AG, Axial Biotherapeutics, Yamo Pharmaceuticals, Curemark


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.4% of the global autism spectrum disorder treatment market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia autism spectrum disorder treatment market is projected to lead the regional market in terms of revenue in 2033.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Autism Spectrum Disorder Treatment Market Scope

Autism spectrum disorder treatment market segmentation & scope
Antipsychotic Drugs
Selective Serotonin Reuptake Inhibitors
Stimulants
Sleep Medications
Others
Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder
Others
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Autism Spectrum Disorder Treatment Market Companies

Name Profile # Employees HQ Website
Curemark View profile 11-50 Rye, New York, United States, North America http://www.curemark.com
Yamo Pharmaceuticals View profile 1-10 New York, New York, United States, North America https://www.yamopharma.com
Axial Biotherapeutics View profile 11-50 Woburn, Massachusetts, United States, North America http://axialtx.com
Otsuka Pharmaceutical View profile 251-500 Tokyo, Tokyo, Japan, Asia https://www.otsuka.co.jp/en/
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Saudi Arabia autism spectrum disorder treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autism spectrum disorder treatment market will help companies and investors design strategic landscapes.


Antipsychotic drugs was the largest segment with a revenue share of 43.53% in 2024. Horizon Databook has segmented the Saudi Arabia autism spectrum disorder treatment market based on antipsychotic drugs, selective serotonin reuptake inhibitors, stimulants, sleep medications covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Saudi Arabia autism spectrum disorder treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia autism spectrum disorder treatment market databook

  • Our clientele includes a mix of autism spectrum disorder treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia autism spectrum disorder treatment market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia autism spectrum disorder treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia autism spectrum disorder treatment market report size, by treatment, 2021-2033 (US$M)

Saudi Arabia Autism Spectrum Disorder Treatment Market Share, 2024 & 2033 (US$M)

Saudi Arabia autism spectrum disorder treatment market report size, by treatment, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online